Products

The mechanism of action of GLP-1 analogues (Liraglutide, Semaglutide) is to activate insulin receptor, promote insulin secretion, reduce glucagon secretion, delay gastric emptying and increase satiety.The mechanism of action of insulin analogue(Insulin Detemir, Insulin Deglutide) is to activate insulin receptor, promote glucose utilization, reduce hepatic glucose output and inhibit ketone body generation.


The above mentioned functions are conducive to reducing postprandial blood glucose and maintaining blood glucose at a constant level, so they can be used for the treatment of diabetes and obesity. Our company provides side chains of various hypoglycemic drugs with high purity, which can meet the needs of customers.


  • somapacitan(LYS/CYS)
    somapacitan(LYS/CYS)



    License is required from license holder. 

    SINOPEG is serving pharmaceutical and medical device companies around the globe, with product presence in various pharmaceutical/device development pipeline (pre-clinical, clinical, and post authorization large scale supply).  Our facility is ISO9001 and ISO13485 certified, and is operating according to ICH Q7A guidelines to produce products for pharmaceutical companies. 


    Please contact us at sales@sinopeg.com for PEG derivatives. Our online catalog or inventory may not listed or have all molecular weights and functional groups, which may be available by custom synthesis. Please contact us at sales@sinopeg.com for quotation and availability. 


  • tirzepatide(LYS/CYS)
    tirzepatide(LYS/CYS)



    License is required from license holder. 

    SINOPEG is serving pharmaceutical and medical device companies around the globe, with product presence in various pharmaceutical/device development pipeline (pre-clinical, clinical, and post authorization large scale supply).  Our facility is ISO9001 and ISO13485 certified, and is operating according to ICH Q7A guidelines to produce products for pharmaceutical companies. 


    Please contact us at sales@sinopeg.com for PEG derivatives. Our online catalog or inventory may not listed or have all molecular weights and functional groups, which may be available by custom synthesis. Please contact us at sales@sinopeg.com for quotation and availability. 


  • semaglutide(LYS/CYS)
    semaglutide(LYS/CYS)



    License is required from license holder. 

    SINOPEG is serving pharmaceutical and medical device companies around the globe, with product presence in various pharmaceutical/device development pipeline (pre-clinical, clinical, and post authorization large scale supply).  Our facility is ISO9001 and ISO13485 certified, and is operating according to ICH Q7A guidelines to produce products for pharmaceutical companies. 


    Please contact us at sales@sinopeg.com for PEG derivatives. Our online catalog or inventory may not listed or have all molecular weights and functional groups, which may be available by custom synthesis. Please contact us at sales@sinopeg.com for quotation and availability. 


  • Insulin icodec (LYS)
    Insulin icodec (LYS)



    License is required from license holder. 

    SINOPEG is serving pharmaceutical and medical device companies around the globe, with product presence in various pharmaceutical/device development pipeline (pre-clinical, clinical, and post authorization large scale supply).  Our facility is ISO9001 and ISO13485 certified, and is operating according to ICH Q7A guidelines to produce products for pharmaceutical companies. 


    Please contact us at sales@sinopeg.com for PEG derivatives. Our online catalog or inventory may not listed or have all molecular weights and functional groups, which may be available by custom synthesis. Please contact us at sales@sinopeg.com for quotation and availability. 


  • Insulin 0143-0406 (LYS)
    Insulin 0143-0406 (LYS)



    License is required from license holder. 
    SINOPEG is serving pharmaceutical and medical device companies around the globe, with product presence in various pharmaceutical/device development pipeline (pre-clinical, clinical, and post authorization large scale supply).  Our facility is ISO9001 and ISO13485 certified, and is operating according to ICH Q7A guidelines to produce products for pharmaceutical companies. 

    Please contact us at sales@sinopeg.com for PEG derivatives. Our online catalog or inventory may not listed or have all molecular weights and functional groups, which may be available by custom synthesis. Please contact us at sales@sinopeg.com for quotation and availability. 


  • Insulin 0123-338(oral) (LYS)
    Insulin 0123-338(oral) (LYS)



    License is required from license holder. 
    SINOPEG is serving pharmaceutical and medical device companies around the globe, with product presence in various pharmaceutical/device development pipeline (pre-clinical, clinical, and post authorization large scale supply).  Our facility is ISO9001 and ISO13485 certified, and is operating according to ICH Q7A guidelines to produce products for pharmaceutical companies. 

    Please contact us at sales@sinopeg.com for PEG derivatives. Our online catalog or inventory may not listed or have all molecular weights and functional groups, which may be available by custom synthesis. Please contact us at sales@sinopeg.com for quotation and availability. 


  • Insulin degludec (LYS)
    Insulin degludec (LYS)



    License is required from license holder. 

    SINOPEG is serving pharmaceutical and medical device companies around the globe, with product presence in various pharmaceutical/device development pipeline (pre-clinical, clinical, and post authorization large scale supply).  Our facility is ISO9001 and ISO13485 certified, and is operating according to ICH Q7A guidelines to produce products for pharmaceutical companies. 


    Please contact us at sales@sinopeg.com for PEG derivatives. Our online catalog or inventory may not listed or have all molecular weights and functional groups, which may be available by custom synthesis. Please contact us at sales@sinopeg.com for quotation and availability. 


  • Levemir
    Levemir (LYS)



    License is required from license holder. 

    SINOPEG is serving pharmaceutical and medical device companies around the globe, with product presence in various pharmaceutical/device development pipeline (pre-clinical, clinical, and post authorization large scale supply).  Our facility is ISO9001 and ISO13485 certified, and is operating according to ICH Q7A guidelines to produce products for pharmaceutical companies. 


    Please contact us at sales@sinopeg.com for PEG derivatives. Our online catalog or inventory may not listed or have all molecular weights and functional groups, which may be available by custom synthesis. Please contact us at sales@sinopeg.com for quotation and availability. 


  • HO-Ste-Glu(AEEA-AEEA-OSu)-OH
    HO-Ste-Glu(AEEA-AEEA-OSu)-OH

    Cas: 1169630-40-3


    Product Name: (S)-22-carboxy-1-((2,5-dioxopyrrolidin-1-yl)oxy)-1,10,19,24-tetraoxo-3,6,12,15-tetraoxa-9,18,23-triazahentetracontan-41-oic acid

    Abbreviation: HO-Ste-Glu(AEEA-AEEA-OSu)-OH

    Molecular Weight: 831

    Package Size: 1g/bottle、10g/bottle、100g/bottle

    Storage: Store at -20±5℃, keep dry.

  • 203787-91-1
    SNAC

    CAS:203787-91-1


    Product Name:Sodium 8-(2-hydroxybenzamido)octanoate

    Abbreviation:SNAC

    Package Size: 1g/bottle、10g/bottle、100g/bottle

    Storage: Store at -20±5℃, keep dry.

    research use only

  • C20-diacid-Trx-γGlu-Glu-PEG3-ethylmaleimide X
    C20-diacid-Trx-γGlu-Glu-PEG3-ethylmaleimide X [HO-Ste-CYH-Glu(OH)-Glu(OH)-AEEEEA-Mal]

    C20-diacid-Trx-γGlu-Glu-PEG3-ethylmaleimide X


    Product Name: C20-diacid-Trx-γGlu-Glu-PEG3-ethylmaleimide X

    Abbreviation: HO-Ste-CYH-Glu(OH)-Glu(OH)-AEEEEA-Mal

    Molecular Weight: 2KDa, 5KDa, 10KDa, 20KDa, 40KDa

    Package Size: 1g/bottle、10g/bottle、100g/bottle

    Storage: Store at -20±5℃, keep dry.

    research use only

first page 1 2 3 4 5 6 7 8 9 last page

A total of 9 pages

Copyright © XIAMEN SINOPEG BIOTECH CO., LTD. All Rights Reserved.

Home

Products

News

contact